Related Experiment Video
Updated: May 3, 2026
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
56.5K
Granulomas in primary biliary cirrhosis: a prognostic feature
Gastroenterology
|December 1, 1981
Summary
Granulomas in liver biopsies may indicate a better prognosis for patients with primary biliary cirrhosis (PBC). This finding suggests granulomas are a significant prognostic indicator, independent of other known factors in PBC.
Area of Science:
- Hepatology
- Immunopathology
Background:
- Primary biliary cirrhosis (PBC) is a chronic liver disease with variable prognosis.
- The role of granulomas in PBC pathogenesis and outcome remains unclear.
Purpose of the Study:
- To investigate the prognostic significance of hepatic granulomas in patients with primary biliary cirrhosis.
- To determine if granulomas are associated with survival outcomes in PBC.
Main Methods:
- Retrospective review of 295 liver biopsy specimens from 100 PBC patients.
- Correlation analysis of granuloma presence with clinical, biochemical, and histological features.
- Evaluation of survival data in relation to granuloma presence, including a subgroup analysis of late-stage PBC patients.
Main Results:
- Granulomas were identified in 54% of patients and were less frequent in advanced histologic stages.
- Granuloma presence did not correlate with clinical presentation or biochemical markers.
- Patients with granulomas showed a significantly better survival rate compared to those without granulomas.
- In late-stage PBC patients, granulomas were associated with improved survival, independent of other prognostic factors.
Conclusions:
- Hepatic granulomas appear to be a significant, independent positive prognostic indicator in primary biliary cirrhosis.
- The presence of granulomas may suggest a more favorable disease course in PBC patients.
- Further research is warranted to elucidate the mechanisms underlying the association between granulomas and improved survival in PBC.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
900
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
01:12Chronic Inflammation: Introduction
41
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
41
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:23Cirrhosis I: Introduction
28
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
01:24Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42